BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17141334)

  • 1. Cannabinoid CB2 receptor: a new target for controlling neural cell survival?
    Fernández-Ruiz J; Romero J; Velasco G; Tolón RM; Ramos JA; Guzmán M
    Trends Pharmacol Sci; 2007 Jan; 28(1):39-45. PubMed ID: 17141334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol inhibits angiogenesis by multiple mechanisms.
    Solinas M; Massi P; Cantelmo AR; Cattaneo MG; Cammarota R; Bartolini D; Cinquina V; Valenti M; Vicentini LM; Noonan DM; Albini A; Parolaro D
    Br J Pharmacol; 2012 Nov; 167(6):1218-31. PubMed ID: 22624859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity.
    Onaivi ES; Ishiguro H; Gu S; Liu QR
    J Psychopharmacol; 2012 Jan; 26(1):92-103. PubMed ID: 21447538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas.
    Stella N
    Glia; 2010 Jul; 58(9):1017-30. PubMed ID: 20468046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.
    Mechoulam R; Ben-Shabat S; Hanus L; Ligumsky M; Kaminski NE; Schatz AR; Gopher A; Almog S; Martin BR; Compton DR
    Biochem Pharmacol; 1995 Jun; 50(1):83-90. PubMed ID: 7605349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
    Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL
    Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids and gliomas.
    Velasco G; Carracedo A; Blázquez C; Lorente M; Aguado T; Haro A; Sánchez C; Galve-Roperh I; Guzmán M
    Mol Neurobiol; 2007 Aug; 36(1):60-7. PubMed ID: 17952650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumors.
    Ellert-Miklaszewska A; Grajkowska W; Gabrusiewicz K; Kaminska B; Konarska L
    Brain Res; 2007 Mar; 1137(1):161-9. PubMed ID: 17239827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.
    Galiègue S; Mary S; Marchand J; Dussossoy D; Carrière D; Carayon P; Bouaboula M; Shire D; Le Fur G; Casellas P
    Eur J Biochem; 1995 Aug; 232(1):54-61. PubMed ID: 7556170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.
    Burstein S
    Bioorg Med Chem; 2015 Apr; 23(7):1377-85. PubMed ID: 25703248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocannabinoid system and the brain.
    Mechoulam R; Parker LA
    Annu Rev Psychol; 2013; 64():21-47. PubMed ID: 22804774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the CB2 receptor system reverses amyloid-induced memory deficiency.
    Wu J; Bie B; Yang H; Xu JJ; Brown DL; Naguib M
    Neurobiol Aging; 2013 Mar; 34(3):791-804. PubMed ID: 22795792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the endocannabinoid system: neuroprotection or neurotoxicity?
    Fowler CJ; Rojo ML; Rodriguez-Gaztelumendi A
    Exp Neurol; 2010 Jul; 224(1):37-47. PubMed ID: 20353772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endocannabinoid system as a target for the treatment of neuronal damage.
    Fernández-Ruiz J; García C; Sagredo O; Gómez-Ruiz M; de Lago E
    Expert Opin Ther Targets; 2010 Apr; 14(4):387-404. PubMed ID: 20230193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoid-mediated control of synaptic transmission.
    Kano M; Ohno-Shosaku T; Hashimotodani Y; Uchigashima M; Watanabe M
    Physiol Rev; 2009 Jan; 89(1):309-80. PubMed ID: 19126760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CB2 receptors in neuroprotective effects of cannabinoids.
    Fernández-Ruiz J; Pazos MR; García-Arencibia M; Sagredo O; Ramos JA
    Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S91-6. PubMed ID: 18291574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of a cannabinoid receptor and functional expression of the cloned cDNA.
    Matsuda LA; Lolait SJ; Brownstein MJ; Young AC; Bonner TI
    Nature; 1990 Aug; 346(6284):561-4. PubMed ID: 2165569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of a peripheral receptor for cannabinoids.
    Munro S; Thomas KL; Abu-Shaar M
    Nature; 1993 Sep; 365(6441):61-5. PubMed ID: 7689702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroinflammation in the Central Nervous System: Exploring the Evolving Influence of Endocannabinoid System.
    Rathod SS; Agrawal YO; Nakhate KT; Meeran MFN; Ojha S; Goyal SN
    Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37893016
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.